Production (Stage)
Protalix BioTherapeutics, Inc.
PLX
$1.58
$0.063.95%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.35% | -21.84% | -33.11% | -6.55% | 46.77% |
| Total Receivables | 24.37% | -41.00% | -75.43% | 150.09% | 188.27% |
| Inventory | -12.71% | 11.54% | -20.31% | 5.52% | 10.06% |
| Prepaid Expenses | -- | 12.61% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 95.81% | -14.73% | -6.67% | -12.59% | 7.12% |
| Total Current Assets | -19.75% | -14.09% | -34.10% | 5.15% | 36.11% |
|
|
|||||
| Total Current Assets | -19.75% | -14.09% | -34.10% | 5.15% | 36.11% |
| Net Property, Plant & Equipment | -6.66% | -7.91% | -2.89% | -1.00% | 7.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.85% | -8.34% | -21.48% | -12.82% | 200.40% |
| Total Assets | -17.74% | -13.05% | -29.70% | 3.53% | 34.96% |
|
|
|||||
| Total Accounts Payable | 30.99% | 4.93% | 0.67% | 23.00% | -38.37% |
| Total Accrued Expenses | 15.41% | 4.57% | -4.33% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -93.49% | -93.07% | -92.99% | 1,635.71% | 1,803.66% |
| Total Finance Division Other Current Liabilities | -76.94% | -8.90% | 21.72% | 1.07% | -33.01% |
| Total Other Current Liabilities | -76.94% | -8.90% | 21.72% | 1.07% | -33.01% |
| Total Current Liabilities | -55.64% | -43.73% | -44.14% | 150.86% | 73.97% |
|
|
|||||
| Total Current Liabilities | -55.64% | -43.73% | -44.14% | 150.86% | 73.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.29% | -12.88% | -7.24% | -6.45% | 8.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -22.61% | -21.71% | -50.03% | -55.88% | -55.97% |
| Total Liabilities | -52.22% | -40.62% | -40.95% | 27.41% | -8.41% |
|
|
|||||
| Common Stock & APIC | 2.77% | 1.56% | 0.86% | 968.44% | 5.51% |
| Retained Earnings | 1.01% | 0.83% | -2.50% | -- | 1.80% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 51.78% | 28.72% | -15.19% | -26.72% | 2,854.96% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 51.78% | 28.72% | -15.19% | -26.72% | 2,854.96% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 51.78% | 28.72% | -15.19% | -26.72% | 2,854.96% |
|
|
|||||